Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2022-03-31 2022-12-20 157650
AMPICILLIN SODIUM FOR INJECTION, USP 1000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86939
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2022-01-27 2022-12-20 153739
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Actual shortage 2025-06-19 2025-12-18 260642
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-05-27 2021-08-06 140036
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2025-04-04 2025-10-10 254136
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2021-08-13 2021-10-07 144105
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2025-06-05 2025-12-11 259685
APRI 21 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10868
APRI 21 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173067
APRI 28 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173064
APRI 28 0.15MG 0.03MG TABLET Resolved 2019-08-29 2019-10-24 92660
APRI 28 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10871
AVIANE 21 20MCG 100MCG TABLET Actual shortage 2025-11-06 2025-11-06 271223
AVIANE 21 20MCG 100MCG TABLET Resolved 2022-09-30 2022-12-02 170770
AVIANE 28 20MCG 100MCG TABLET Resolved 2022-09-07 2022-12-02 168716
AVIANE 28 20MCG 100MCG TABLET Actual shortage 2025-11-06 2025-11-06 271226
AVIANE 28 20MCG 100MCG TABLET Resolved 2019-09-26 2019-11-01 94828
AVIANE 28 20MCG 100MCG TABLET Resolved 2021-07-29 2021-09-30 143256
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RASAGILINE 1MG TABLET Reversed 2025-05-28 2025-06-04 258753
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258473
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-04-29 2025-04-29 256079
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-RISPERIDONE 2MG TABLET Reversed 2025-05-28 2025-06-04 258679
TEVA-RISPERIDONE 3MG TABLET Reversed 2025-05-28 2025-06-04 258685
TEVA-RISPERIDONE 1MG TABLET Reversed 2025-05-28 2025-06-04 258673
TEVA-RISPERIDONE 0.25MG TABLET Reversed 2025-05-28 2025-06-04 258711
TEVA-RISPERIDONE 4MG TABLET Reversed 2025-05-28 2025-06-04 258688
TEVA-ROSUVASTATIN 20MG TABLET Reversed 2025-05-28 2025-06-04 258765
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-SPIRONOLACTONE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258486
TEVA-SUCRALFATE 1G TABLET Discontinued 2025-09-02 2025-09-02 266359
TEVA-TECNAL 330MG 40MG 50MG CAPSULE Discontinued 2025-05-28 2025-05-28 258478
TEVA-TECNAL 50MG 330MG 40MG TABLET Discontinued 2025-05-28 2025-05-28 258471
TEVA-TECNAL C 1/2 50MG 330MG 30MG 40MG CAPSULE Discontinued 2025-05-28 2025-05-28 258462